Peter Attia MD#102–Michael Osterholm, PhD: COVID-19—Challenges ahead & reasons for optimism and concern
Episode Details
EPISODE INFO
- Released
- March 31, 2020
- Duration
- 1h 22m
- Channel
- Peter Attia MD
- Watch on YouTube
- ▶ Open ↗
EPISODE DESCRIPTION
Sign up to receive Peter's email newsletter: https://bit.ly/4c602k2 Full title: #102 – Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concern In this episode, Michael Osterholm, Director of the Center for Infectious Disease Research and Policy at the University of Minnesota and author of Deadliest Enemy: Our War Against Killer Germs, provides an overview on the COVID-19 pandemic in regards to what has happened to date, what we’ve learned about how the disease spreads, and his optimism and pessimism about what potentially lies ahead. Michael gives his take on the true case fatality rate, why it differs around the world, and which underlying conditions, such as obesity, impact risk of severe illness and death. We also discuss the outlook regarding vaccines, repurposed drugs/antivirals for treatment, and Michael’s growing concern about supply chain limitations with respect to drugs, vaccines, n95 masks, and testing kits. We discuss: -Recapping the brief history of COVID-19 and what potentially lies ahead [2:15]; -Some positive news about immunity and reinfection [10:45]; -Case fatality rate—the challenge in finding the true rate, difference by country, and the impact of age, underlying conditions, and obesity [13:00]; -What has to be true for less than 100,000 Americans to die from COVID-19? [24:30]; -How do we best protect healthcare workers? [29:45]; -Concerns about testing capability—reagent shortfall and a supply chain problem [39:30]; -Vaccines and antivirals—The outlook, timing, and challenges [47:45]; -Long term health of survivors of COVID-19 [56:45]; -The impact of comorbidities—Diabetes, obesity, and immunosuppressed patients [59:30]; -Understanding R0 and how the disease spreads [1:01:30]; -The challenge of forecasting with so many unknowns [1:08:00]; -What explains the difference in cases and fatalities in different parts of the world? [1:14:30]; -Repurposed drugs/antivirals being considered for treatment options—any optimism? [1:16:45]; -A parting message from Michael about what lies ahead [1:18:30]; and -More. Show notes page: https://peterattiamd.com/michaelosterholm/ -------- About: The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 30 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more. Peter is a physician focusing on the applied science of longevity. His practice deals extensively with nutritional interventions, exercise physiology, sleep physiology, emotional and mental health, and pharmacology to increase lifespan (delay the onset of chronic disease), while simultaneously improving healthspan (quality of life). Learn more: https://peterattiamd.com Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter Connect with Peter on: Facebook: http://bit.ly/PeterAttiaMDFB Twitter: http://bit.ly/PeterAttiaMDTW Instagram: http://bit.ly/PeterAttiaMDIG Subscribe to The Drive: Apple Podcast: http://bit.ly/TheDriveApplePodcasts Overcast: http://bit.ly/TheDriveOvercast Spotify: http://bit.ly/TheDriveSpotify Google Podcasts: http://bit.ly/TheDriveGoogle
SPEAKERS
Peter Attia
hostPhysician and host of "The Drive" podcast.
Michael Osterholm
guestEpidemiologist and infectious disease expert focused on pandemic preparedness and response.
EPISODE SUMMARY
In this episode of Peter Attia MD, featuring Peter Attia and Michael Osterholm, #102–Michael Osterholm, PhD: COVID-19—Challenges ahead & reasons for optimism and concern explores osterholm Warns of Prolonged COVID-19 Spread, Shortages, and Limited Easy Solutions Osterholm says he expects transmission to continue until roughly 50 to 70% of the population is infected unless it is suppressed, and sees no easy path between a Wuhan-style shutdown and uncontrolled spread.
RELATED EPISODES
